The lawsuit claims complications have frequently been experienced by those receiving the Gardasil HPV vaccination, but Merck has failed to provide adequate warnings to potential recipients.
The first Gardasil vaccine lawsuits are expected to be ready for bellwether trials in mid to late 2024.
The Gardasil lawsuit claims the HPV vaccine injection left plaintiff with permanent injuries and an inability to engage in most physical activities.
Plaintiff was rejected by the Navy due to his gastrointestinal problems caused by autoimmune problems after an HPV vaccine with Gardasil
Data on all Gardasil adverse events must be turned over to plaintiffs, as well as information on its key opinion leaders on the HPV vaccine and numerous other internal documents.
Lawsuit alleges woman was sent into menopause in her 20s, due to the procedures needed to treat her Gardasil cervical cancer diagnosis
Claims will go through case-specific discovery and be eligible for the first Gardasil bellwether trials beginning in late 2024 or early 2025.
All individuals who file a Gardasil vaccine injury claim will be required to complete a Plaintiff Fact Sheet, providing certain details about their vaccination and problems experienced
Gardasil caused progressing symptoms for a 17 year old girl, eventually resulting in chronic life-long injuries and disability, according to a lawsuit over the HPV vaccine
Merck penalized states and districts who purchased a competitive vaccine by driving up prices on bundles of other children's vaccines it monopolizes, according to the rotavirus vaccine class action lawsuit.
